Romain Remark

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Addendum: RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.

Addendum: RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.

Journal: The Journal of experimental medicine
Published: July 24, 2026

CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosis.

CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosis.

Journal: Translational oncology
Published: November 13, 2025

A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma.

A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma.

Journal: Science immunology
Published: November 15, 2024

Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers.

Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers.

Journal: Cellular & molecular immunology
Published: February 11, 2023

Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.

Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.

Journal: Gut
Published: November 12, 2021

Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.

Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.

Journal: Open research Europe
Published: October 18, 2021

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.

Journal: Cell reports. Medicine
Published: October 04, 2021

Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.

Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.

Journal: Gastroenterology
Published: August 20, 2021

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.

Journal: Nature
Published: April 29, 2020

Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.

Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 11, 2019

Host tissue determinants of tumour immunity.

Host tissue determinants of tumour immunity.

Journal: Nature reviews. Cancer
Published: March 15, 2019

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.

Journal: Cell
Published: December 05, 2018
Showing 1-12 of 37

Last Updated: 09/26/2026